Topical application of nanoparticles integrated supramolecular hydrogels for the potential treatment of seborrhoeic dermatitis / Abhinava Garg, Charan Singh, Deepak Pradhan, Goutam Ghosh, Goutam Rath
Abstract The current application was aimed to evaluate the therapeutic potential of selenium and ketoconazole nanoparticles loaded hyaluronic acid gel against seborrhoeic dermatitis (SD). Amalgamation of ketoconazole (antifungal medication) and selenium (pro-oxidant) in an optimized formulation setting may help in the treatment of SD. In this study, selenium and ketoconazole nanoparticles loaded hyaluronic acid (HA) hydrogel was prepared by mechanical mixing followed by sonication. Results of the optimized batch showed a mean particle size of 121 ± 12 nm for ketoconazole and 51 ± 7 nm for selenium. SEM and TEM study revealed the prepared nanoparticles are of nanoscale dimension, with smooth spherical outline. Finally, the optimized nanoparticles were incorporated into HA hydrogel. Hydrogel exhibits desirable physical, mechanical and rheological characteristics appropriate for topical application. Optimized gel formulation exhibited an enhanced permeability with better antifungal, and anti-inflammatory activities, compared with the plain drug suspension. The optimized hydrogel with ketoconazole and selenium in nanotemplate could offer a potential strategy for the treatment of SD. Graphical Abstract.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Pharmaceutical development and technology - 25(2020), 6, Seite 748-756 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Garg, Abhinava [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Themen: |
Hyaluronic acid |
---|
Umfang: |
1 Online-Ressource (9 p) |
---|
doi: |
10.1080/10837450.2020.1740932 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
KFL011207957 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL011207957 | ||
003 | DE-627 | ||
005 | 20230720210310.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230714s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10837450.2020.1740932 |2 doi | |
035 | |a (DE-627)KFL011207957 | ||
035 | |a (KFL)prod_LgpH_10.1080/10837450.2020.1740932 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Garg, Abhinava |e verfasserin |4 aut | |
245 | 1 | 0 | |a Topical application of nanoparticles integrated supramolecular hydrogels for the potential treatment of seborrhoeic dermatitis |c Abhinava Garg, Charan Singh, Deepak Pradhan, Goutam Ghosh, Goutam Rath |
264 | 1 | |c 2020 | |
300 | |a 1 Online-Ressource (9 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract The current application was aimed to evaluate the therapeutic potential of selenium and ketoconazole nanoparticles loaded hyaluronic acid gel against seborrhoeic dermatitis (SD). Amalgamation of ketoconazole (antifungal medication) and selenium (pro-oxidant) in an optimized formulation setting may help in the treatment of SD. In this study, selenium and ketoconazole nanoparticles loaded hyaluronic acid (HA) hydrogel was prepared by mechanical mixing followed by sonication. Results of the optimized batch showed a mean particle size of 121 ± 12 nm for ketoconazole and 51 ± 7 nm for selenium. SEM and TEM study revealed the prepared nanoparticles are of nanoscale dimension, with smooth spherical outline. Finally, the optimized nanoparticles were incorporated into HA hydrogel. Hydrogel exhibits desirable physical, mechanical and rheological characteristics appropriate for topical application. Optimized gel formulation exhibited an enhanced permeability with better antifungal, and anti-inflammatory activities, compared with the plain drug suspension. The optimized hydrogel with ketoconazole and selenium in nanotemplate could offer a potential strategy for the treatment of SD. Graphical Abstract | ||
653 | |a Selenium | ||
653 | |a ketoconazole | ||
653 | |a hyaluronic acid | ||
653 | |a hydrogel | ||
653 | |a seborrhoeic dermatitis | ||
700 | 1 | |a Singh, Charan |e verfasserin |4 aut | |
700 | 1 | |a Pradhan, Deepak |e verfasserin |4 aut | |
700 | 1 | |a Ghosh, Goutam |e verfasserin |4 aut | |
700 | 1 | |a Rath, Goutam |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmaceutical development and technology |d Abingdon : Taylor & Francis Group, 1996 |g 25(2020), 6, Seite 748-756 |h Online-Ressource |w (DE-627)KFL000006017 |w (DE-600)2028095-6 |w (DE-576)273908782 |x 1097-9867 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2020 |g number:6 |g pages:748-756 |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.1080/10837450.2020.1740932 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-TFE | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
935 | |i IMPORT_0628_prod_LgpH_02 | ||
951 | |a AR | ||
952 | |d 25 |j 2020 |e 6 |h 748-756 |